Sr One Capital Management, Llc bought $27.2M of ADARx Pharmaceuticals (ADRX)

Executed Sep 28, disclosed Sep 30, 1 day later.

Value, as filed

$27.2M

1,600,000 sh across 3 lots

Executed

Sep 28

the trade date, as filed

Disclosed

Sep 30

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

SL Sr One Capital Management, Llc 10% owner profile →

Sr One Capital Management, Llc (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (4 purchases, 0 sales), most often in ADARx Pharmaceuticals, Inc. (ADRX). Across 3 priced purchase filings, the average 21-session return was +7.4% from execution and +11.3% from disclosure (delay-adjusted; derived). The largest single filing was $27.2M of ADRX (1,600,000 sh across 3 lots, as filed), executed Sep 28.

The name

ADRX

ADARx Pharmaceuticals, Inc. ADRX · Healthcare · 5 filings in 24 months ticker →

Healthcare · ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a bro…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→